Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma
Clinical trial NCT02875067 · TERMINATED
Trial details
- NCT number
- NCT02875067
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-29
- Primary completion
- 2017-10-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.